Keywords: Diagnosis/Prediction, Cancer, TNBC, DCE-MRI, treatment response
Motivation: Accurate prediction of the response to neoadjuvant immunochemotherapy (NICT) in triple negative breast cancer (TNBC) is valuable in guiding individualized treatment.
Goal(s): To develop a deep learning-based model to predict response before the initiation of NICT.
Approach: Our deep-learning model used pretreatment DCE-MRI from 100 TNBC patients.
Results: Although preliminary and limited by a small patient number, our model yielded an average AUC of 0.63 in predicting the response to NICT in an independent testing.
Impact: A deep learning model has the potential to predict TNBC response to NICT before treatment and to help with the clinical management.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords